Holen Sie sich die Stockscreener-App
0.00
100.00%
-79.97
Schlusskurs vom Vortag:
$79.97
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$4.67B
Einnahmen:
$574.50M
Nettoeinkommen (Verlust:
$-78.58M
KGV:
0.00
EPS:
-1.35
Netto-Cashflow:
$1.58M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$79.99
Inari Medical Inc Stock (NARI) Company Profile
Firmenname
Inari Medical Inc
Sektor
Branche
Telefon
949-923-4747
Adresse
6001 OAK CANYON, SUITE 100, IRVINE, CA
Vergleichen Sie NARI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NARI
Inari Medical Inc
|
0.00 | 4.67B | 574.50M | -78.58M | 1.58M | -1.35 |
|
ABT
Abbott Laboratories
|
133.58 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.09 | 155.73B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
383.89 | 146.23B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.44 | 106.37B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.52 | 45.88B | 5.54B | 4.18B | 623.10M | 7.00 |
Inari Medical Inc Stock (NARI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-17 | Eingeleitet | Oppenheimer | Outperform |
| 2024-09-18 | Eingeleitet | Stifel | Hold |
| 2024-09-03 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-08-09 | Eingeleitet | Deutsche Bank | Buy |
| 2024-07-25 | Eingeleitet | William Blair | Outperform |
| 2024-07-18 | Herabstufung | Needham | Buy → Hold |
| 2024-02-29 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-01-23 | Eingeleitet | Needham | Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-09-29 | Eingeleitet | Berenberg | Buy |
| 2022-09-13 | Eingeleitet | Truist | Hold |
| 2022-06-21 | Eingeleitet | Piper Sandler | Overweight |
| 2022-03-23 | Fortgesetzt | BofA Securities | Buy |
| 2020-12-15 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2020-11-18 | Eingeleitet | BTIG Research | Buy |
| 2020-10-29 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-09-28 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-19 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-06-16 | Eingeleitet | BofA/Merrill | Neutral |
| 2020-06-16 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-06-16 | Eingeleitet | Wells Fargo | Equal Weight |
Alle ansehen
Inari Medical Inc Aktie (NARI) Neueste Nachrichten
Levi & Korsinsky Reminds Inari Medical Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 12, 2024NARI - ACCESS Newswire
SHAREHOLDER ALERT: Inari Medical Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - ACCESS Newswire
NARI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Inari Medical, Inc. Shareholders to Contact the Firm! - ACCESS Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 12, 2024 in Inari Medical, Inc. Lawsuit – NARI - ACCESS Newswire
Inari Medical, Inc. (NARI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Did Inari Medical, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky InvestigateNARI - ACCESS Newswire
Shareholders that lost money on Inari Medical, Inc.(NARI) should contact Levi & Korsinsky about pending Class ActionNARI - ACCESS Newswire
Lost Money on Inari Medical, Inc.(NARI)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Investors who lost money on Inari Medical, Inc.(NARI) should contact Levi & Korsinsky about pending Class ActionNARI - ACCESS Newswire
Press Release Distribution & PR Platform - ACCESS Newswire
Lost Money on Inari Medical, Inc.(NARI)? Contact Levi & Korsinsky Regarding an Ongoing Investigation - ACCESS Newswire
Inari Medical, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – NARI - ACCESS Newswire
Inari Medical, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More InformationNARI - ACCESS Newswire
Shareholders of Inari Medical, Inc. Should Contact Levi & Korsinsky Before July 12, 2024 to Discuss Your RightsNARI - ACCESS Newswire
Class Action Filed Against Inari Medical, Inc. (NARI) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire
An Investigation Has Commenced on Behalf of Inari Medical, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your NARI Losses - ACCESS Newswire
Inari Medical, Inc. (NARI) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky, LLP Investigates - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Inari Medical, Inc. (NARI) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Finanzdaten der Inari Medical Inc-Aktie (NARI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.56%
1.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):